Welcome to our dedicated page for Oxbridge Re Hldg SEC filings (Ticker: OXBRW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reinsurance filings can read like a risk model—dense tables, catastrophe acronyms, and reserve roll-forwards scattered across hundreds of pages. Oxbridge Re Holdings investors face an added twist: fully collateralized contracts that demand extra disclosure. If you have ever asked, “How do I find Oxbridge Re Holdings insider trading Form 4 transactions or track its hurricane-season updates?”, this page removes the frustration.
Stock Titan’s AI untangles every document the moment it reaches EDGAR. Need the Oxbridge Re Holdings quarterly earnings report 10-Q filing? Our engine highlights premium growth, loss ratios, and collateral trust balances in plain language. Curious about reserve changes after a storm? The platform flags any Oxbridge Re Holdings 8-K material events explained within minutes. You can even set real-time alerts for Oxbridge Re Holdings Form 4 insider transactions real-time to see when executives adjust positions.
Each filing type answers a different question: the Oxbridge Re Holdings annual report 10-K simplified breaks down catastrophe exposure by region; 10-Qs reveal quarter-over-quarter reserve releases for quick Oxbridge Re Holdings earnings report filing analysis; proxy statements cover Oxbridge Re Holdings proxy statement executive compensation; and our dashboards surface every Oxbridge Re Holdings executive stock transactions Form 4. Looking for guidance on actuarial terms or collateral triggers? Try “understanding Oxbridge Re Holdings SEC documents with AI” and let our summary mode translate technical language.
From loss triangles to management commentary, Oxbridge Re Holdings SEC filings explained simply are a click away—complete, current, and interpreted by AI so you can focus on decisions, not document hunting.
Allan S. Martin, a director of Oxbridge Re Holdings Ltd (OXBR), reported sales of ordinary shares on 08/27/2025. The Form 4 shows two sell transactions: 3,449 shares sold at $2.3948 and 6,551 shares sold at $2.3812. After those transactions the filing reports beneficial ownership figures of 227,682 and 221,131 (reported on separate lines) for the direct holdings shown. The filing also discloses 68,770 ordinary shares held indirectly by Fleur de Lis Partners, LLLP and 102,223 ordinary shares held indirectly by the Martin Family Foundation, Inc., with Mr. Martin described as having voting and/or investment power over those entities' holdings. The form is signed by an attorney-in-fact on 08/29/2025.
Armistice Capital, LLC and Steven Boyd report collective beneficial ownership of 395,792 ordinary shares of Oxbridge Re Holdings Ltd, representing 4.99% of the class. The shares are held directly by Armistice Capital Master Fund Ltd., for which Armistice Capital serves as investment manager; Armistice Capital and Mr. Boyd each report shared voting and shared dispositive power over these shares and report no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and were not acquired to effect a change of control. The Master Fund disclaims direct beneficial ownership to the extent it lacks voting or dispositive power under its investment management agreement.
Oxbridge Re Holdings Limited (Nasdaq: OXBR) filed an 8-K on 9 July 2025 announcing it has entered into a new $5 million at-the-market Equity Distribution Agreement with Maxim Group LLC. The agreement authorises the agent to sell ordinary shares from time to time on the Nasdaq Capital Market or other trading venues at prevailing prices. Either party may terminate the arrangement with 30 days’ notice or once the full $5 million capacity is reached. Oxbridge will pay a 3.0 % sales commission on gross proceeds.
The facility replaces the September 30 2022 ATM agreement under which the company raised $4.6 million. The company is under no obligation to issue shares and may instruct the Sales Agent on price, time and amount parameters. Net proceeds are earmarked for general corporate purposes, including funding of the company’s reinsurance operations; pending deployment, proceeds will be invested in cash or short-term investment-grade instruments.
Shares offered under the ATM are being drawn from the company’s existing shelf registration statement (Form S-3, File No. 333-287186). In line with General Instruction I.B.6, up to $517,745 of ordinary shares are currently registered, with additional prospectus supplements required for further capacity. Supporting documents include the Equity Distribution Agreement (Exhibit 1.1) and Cayman legal opinion (Exhibit 5.1).
FAQ
What is the current stock price of Oxbridge Re Hldg (OXBRW)?
What is the market cap of Oxbridge Re Hldg (OXBRW)?
